Paola Munoz-Tello

Paola Munoz-Tello

Auto-generated profile, based on publicly available information

Paola Munoz-Tello

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, FL 33458, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in eLife
Verified
Journal Article
Open access
JSJinsai Shang
Jinsai Shang
RBRichard Brust
Richard Brust
SMSarah A Mosure
Sarah A Mosure
JBJared Bass
Jared Bass
PMPaola Munoz-Tello
Paola Munoz-Tello
DKDouglas Kojetin
Douglas Kojetin
Crystal structures of peroxisome proliferator-activated receptor gamma (PPARγ) have revealed overlapping binding modes for synthetic and natural/endogenous ligands, indicating competition for the orthosteric pocket. Here we show that cobinding of a synthetic ligand to the orthosteric pocket can push natural and endogenous PPARγ ligands (fatty acids) out of the orthosteric pocket towards an alternate ligand-binding site near the functionally important omega (Ω)-loop. X-ray crystallography, NMR spectroscopy, all-atom molecular dynamics simulations, and mutagenesis coupled to quantitative biochemical functional and cellular assays reveal that synthetic ligand and fatty acid cobinding can form a ‘ligand link’ to the Ω-loop and synergistically affect the structure and function of PPARγ. These findings contribute to a growing body of evidence indicating ligand binding to nuclear receptors can be more complex than the classical one-for-one orthosteric exchange of a natural or endogenous ligand with a synthetic ligand.

29 April 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
IVIan Mitchelle S. de Vera
Ian Mitchelle S. de Vera
PGPankaj K. Giri
Pankaj K. Giri
PMPaola Munoz-Tello
Paola Munoz-Tello
RBRichard Brust
Richard Brust
JFJakob Fuhrmann
Jakob Fuhrmann
DKDouglas Kojetin
Douglas Kojetin

1 October 2017 in Structure
Verified
Journal Article
Closed access
IVIan Mitchelle S. de Vera
Ian Mitchelle S. de Vera
JZJie Zheng
Jie Zheng
SNScott Novick
Scott Novick
JSJinsai Shang
Jinsai Shang
THTravis S. Hughes
Travis S. Hughes
DKDouglas Kojetin
Douglas Kojetin

1 January 2019 in Structure
Verified
Journal Article
Closed access
IVIan Mitchelle S. de Vera
Ian Mitchelle S. de Vera
PMPaola Munoz-Tello
Paola Munoz-Tello
JZJie Zheng
Jie Zheng
VDVenkatasubramanian Dharmarajan
Venkatasubramanian Dharmarajan
David MarcianoDavid Marciano
David Marciano
DKDouglas Kojetin
Douglas Kojetin

1 June 2012 in Structure
Verified
Journal Article
Closed access
PMPaola Munoz-Tello
Paola Munoz-Tello
CGCaroline Gabus
Caroline Gabus
STStéphane Thore
Stéphane Thore

11 May 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PMPaola Munoz-Tello
Paola Munoz-Tello
LRLional Rajappa
Lional Rajappa
SCSandrine Coquille
Sandrine Coquille
STStéphane Thore
Stéphane Thore
In eukaryotes, mRNA polyadenylation is a well-known modification that is essential for many aspects of the protein-coding RNAs life cycle. However, modification of the 3′ terminal nucleotide within various RNA molecules is a general and conserved process that broadly modulates RNA function in all kingdoms of life. Numerous types of modifications have been characterized, which are generally specific for a given type of RNA such as the CCA addition found in tRNAs. In recent years, the addition of nontemplated uridine nucleotides or uridylation has been shown to occur in various types of RNA molecules and in various cellular compartments with significantly different outcomes. Indeed, uridylation is able to alter RNA half-life both in positive and in negative ways, highlighting the importance of the enzymes in charge of performing this modification. The present review aims at summarizing the current knowledge on the various processes leading to RNA 3′-end uridylation and on their potential impacts in various diseases.